BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 18, 2004
View Archived Issues
Replidyne Raises $40M, Adds To Pipeline With Antibacterial Drug
Replidyne Inc. closed its largest financing, a $40 million second round, and concurrently in-licensed a late-stage compound to treat bacterial infections. (BioWorld Today)
Read More
XOMA's Acne Gel Stumbles In Phase II; Stock Falls 35 Percent
Read More
UK Clears Cloning Embryos For Extraction Of Stem Cells
Read More
CyDex Series B Nets $17M For Internal Drug Programs
Read More
Other News To Note
Read More